Celgene Director, Translational Medicine (MD) in San Francisco, California
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Responsibilities include, but are not limited to, the following:
Translational Development Functions:
Part of the TD Leadership team responsible for defining and positioning the early oncology portfolio in collaboration with VP, Translational Development and colleagues in research, clinical development, and marketing
Medical lead for clinical trials in hematology and oncology from Candidate Nomination (pre-IND) through Proof-of-Concept including:
Articulating the clinical development strategy
Design, implementation and analysis of early stage clinical trials
Clinical leadership on cross-functional Early Development project teams
Close liaison with Translational Development Scientists, Discovery and Development Teams for defining Clinical PD or Biomarker assays.
Responsible for clinical drug safety monitoring and management, in conjunction with the drug safety physician
Ad Hoc member of the Candidate Development Committee, that evaluates all IND candidates and Early Development programs
Key resource for disease area expertise for the TD team.
Liaise with clinical and laboratory-based academic investigators in Early Oncology and be a focal point for defining and establishing relationships with key Global Phase 1 Centers.
Part of the team responsible for establishing key alliances with academic centers, co-operative groups, vendors and government agencies for cost effective implementation of Celgene’s R & D and early development strategy
Participate in formulating disease area strategy for target selection and validation
Provide support to Business Development and the established teams, for potential in-licensing opportunities that may include potential therapeutics, emerging technologies, processes or capabilities that will enhance our Drug Discovery and Early Development efforts.
MD or M.D./PhD with at least 4 years of post-graduate work experience in Early/Translational Development. Subspecialty board certification in hematology/oncology strongly preferred.
6 or more years relevant experience in clinical/translational research with at least 4 years of post-graduate experience working on Translational Development activities (e.g., IND submittals, Proof-of-Concept studies, phase I/II clinical studies, adaptive design studies, biomarker development, companion diagnostics, mechanism of action studies).
Demonstrated experience interacting with scientists on discovery research and/or translational development projects in hematology/oncology
Proven record of building, leading and integrating cross-functional groups
Track record in leading innovative efforts to deploy technologies and assays for enhanced translational capabilities
Superior leadership, management and organizational skills, and a reputation as an open, available and transparent communicator
Management experience (through direct reports or matrix organization) coupled with strong interpersonal, oral and written communication skills. Strong leadership in representing Translational Developments positions to Senior Management and Executive Committees and International Forums.
Ability to interact effectively across boundaries using influencing and relationship building skills.
Ability to function at the interface of both the Discovery and Development teams, with the aim of providing the successful implementation of stratification strategies, clinical biomarker and pharmacodynamic assays in the early clinical studies
Competence in analysis and solving of problems, and the ability to prioritize and make tradeoffs to achieve goals.
Domestic and international travel is expected as required.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.